Abstract
Purpose
Primary immunodeficiency (PID) diseases are rare, complex medical disorders that often are overlooked in clinical settings. There are emerging reports of PID from Middle Eastern populations. This study describes the features of PID patients in a tertiary care setting in Oman and compares them with regional and worldwide reports.
Method
Sultan Qaboos University Hospital (SQUH) is an academic tertiary care-level hospital for specialized healthcare, including PID patients. At the time of diagnosis, patients’ sociodemographics, clinical features, laboratory investigations, and management were entered in electronic form. This study included patients seen between August 2005 and July 2015.
Results
One hundred forty patients were registered with a minimum estimated population prevalence of 7.0/100,000. The male/female ratio was 1.6:1, the median age of onset of symptoms was 8 months, and diagnosis was 21 months with a delay of 13 months. Family history was positive in 44 %, consanguinity was present in 76 %, death of a previous sibling was present in 36 %, and there was an overall mortality in 18 %, with an 85 % probability of survival 10 years following diagnosis. The most common type of immunodeficiency was phagocytic disorders (35.0 %), followed by predominantly antibody disorders (20.7 %), combined immunodeficiency (17.8 %), other well-defined PID syndromes (15.0 %), immune dysregulation syndromes (3.5 %), complement deficiencies (3.5 %), and unclassified immunodeficiency (4.2 %). The commonest presenting infection was pneumonia (47.1 %).
Conclusion
PID is not a rare condition in Oman. The prevalence is in concordance with reports from the region but higher than in Western populations. The findings of the current study would help to improve the awareness and management of, and policy making for PID.
Similar content being viewed by others
References
Bonilla FA, Geha RS. Immunologic disorders 12. Primary immunodeficiency diseases. J Allergy Clin Immunol. 2003;111(2 sppl):s571–81.
Carneiro-Sampaio M, Coutinho A. Early-onset autoimmune disease as a manifestation of primary immunodeficiency. Front Immunol. 2015;6:185. doi:10.3389/fimmu.2015.00185.
Raptaki M, Varela I, Spanou K, Tzanoudaki M, Tantou S, Liatsis M, et al. Chronic granulomatous disease: a 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece. J Clin Immunol. 2013;33(8):1302–9. doi:10.1007/s10875-013-9940-z.
Grumach AS, Kirschfink M. Are complement deficiencies really rare? Overview onprevalence, clinical importance and modern diagnostic approach. Mol Immunol. 2014;61(2):110–7. doi:10.1016/j.molimm.2014.06.030.
Norouzi S, Aghamohammadi A, Mamishi S, Rosenzweig SD, Rezaei N. Bacillus Calmette-Guerin (BCG) complications associated with primary immunodeficiency diseases. J Infect. 2012;64(6):543–54. doi:10.1016/j.**f.2012.03.012.
Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova J-L, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33(1):1–7. doi:10.1007/s10875-012-9751-7.
Reda SM, El-Ghoneimy DH, Afifi HM. Clinical predictors of primary immunodeficiency diseases in children. Allergy, Asthma Immunol Res. 2013;5(2):88–95. doi:10.4168/aair.2013.5.2.88.
Routes J, Abinun M, Al-herz W, Bustamante J, Condino-neto A, Teresa M, et al. The early diagnosis of congenital immunodeficiencies. J Clin Immunol. 2014;34(4):398–424. doi:10.1007/s10875-014-0003-x.
Kobrynski L, Powell RW, Bowen S. Prevalence and morbidity of primary immunodeficiency diseases, United States 2001–2007. J Clin Immunol. 2014;34(8):954–61. doi:10.1007/s10875-014-0102-8.
Oliveira JB, Fleisher TA. Laboratory evaluation of primary immunodeficiencies. J Allergy Clin Immunol. 2010;125(2):S297–305. doi:10.1016/j.jaci.2009.08.043.
Orange JS, Ballow M, Stiehm ER, Ballas ZK, Chinen J, De La Morena M, et al. Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2012;130(3 Suppl):S1–24. doi:10.1016/j.jaci.2012.07.002.
Ballow M. Vaccines in the assessment of patients for immune deficiency. J Allergy Clin Immunol. 2012;130(1):283–4. doi:10.1016/j.jaci.2012.04.028. e5.
Blumental S, Mouy R, Mahlaoui N, Bougnoux ME, Debré M, Beauté J, et al. Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey. Clin Infect Dis. 2011;53(12):e159–69. doi:10.1093/cid/cir731.
Gantzer A, Neven B, Picard C, Brousse N, Lortholary O, Fischer A, et al. Severe cutaneous bacillus Calmette-Guérin infection in immunocompromised children: the relevance of skin biopsy. J Cutan Pathol. 2013;40(1):30–7. doi:10.1111/cup.12048.
Lanari M, Vandini S, Capretti MG, Lazzarotto T, Faldella G. Respiratory syncytial virus infections in infants affected by primary immunodeficiency. J Immunol Res. 2014;2014:1–6. doi:10.1155/2014/850831.
Jesenak M, Banovcin P, Jesenakova B, Babusikova E. Pulmonary manifestations of primary immunodeficiency disorders in children. Front Pediatr. 2014;2:77. doi:10.3389/fped.2014.00077.
Sambatakou H, Guiver M, Denning D. Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction andserological tests, and successful treatment with voriconazole. Eur J ClinMicrobiol Infect Dis. 2003;22(11):681–5.
Pai S-Y, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency, 2000–2009. N Engl J Med. 2014;371(5):434–46. doi:10.1056/NEJMoa1401177.
Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenousimmunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol. 2002;109(6):1001–4.
Pachlopnik Schmid J, Güngör T, Seger R. Modern management of primary T-cell immunodeficiencies. Pediatr Allergy Immunol. 2014;25(4):300–13. doi:10.1111/pai.12179.
Al-Herz W, Zainal ME, Alenezi HM, Husain K, Alshemmari SH. Performance status and deaths among children registered in Kuwait National Primary Immuno Deficiency Disorders Registry. Asian Pac J Allergy Immunol. 2010;28(2–3):141–6.
CEREDIH: The French PID study group. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135(2):264–72. doi:10.1016/j.clim.2010.02.021.
Gathmann B, Goldacker S, Klima M, Belohradsky BH, Notheis G, Ehl S, et al. The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol. 2013;173(2):372–80. doi:10.1111/cei.12105.
Edgar JD, Buckland M, Guzman D, Conlon NP, Knerr V, Bangs C, et al. The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years’ activity 2008–2012. Clin Exp Immunol. 2014;175(1):68–78. doi:10.1111/cei.12172.
Aghamohammadi A, Moein M, Farhoudi A, Pourpak Z, Rezaei N, Abolmaali K, et al. Primary immunodeficiency in Iran: first report of the national registry of PID in children and adults. J Clin Immunol. 2002;22(6):375–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12462337.
Mellouli F, Mustapha IB, Khaled MB, Besbes H, Ouederni M, Mekki N, et al. Report of the Tunisian registry of primary immunodeficiencies: 25-years of experience (1988–2012). J Clin Immunol. 2015;35(8):745–53. doi:10.1007/s10875-015-0206-9.
Al-Herz W, Zainal ME, Salama M, Al-Ateeqi W, Husain K, Abdul-Rasoul M, et al. Primary immunodeficiency disorders: survey of pediatricians in Kuwait. J Clin Immunol. 2008;28(4):379–83. doi:10.1007/s10875-008-9191-6.
Ehlayel MS, Bener A, Laban MA. Primary immunodeficiency diseases in children: 15 year experience in a tertiary care medical center in Qatar. J Clin Immunol. 2013;33(2):317–24. doi:10.1007/s10875-012-9812-y.
Al-Saud B, Al-Mousa H, Al Gazlan S, Al-Ghonaium A, Arnaout R, Al-Seraihy A, et al. Primary immunodeficiency diseases in Saudi Arabia: a tertiary care hospital experience over a period of three years (2010–2013). J Clin Immunol. 2015;35(7):651–60. doi:10.1007/s10875-015-0197-6.
Bousfiha AA, Jeddane L, El Hafidi N, Benajiba N, Rada N, El Bakkouri J, et al. First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998–2012). J Clin Immunol. 2014;34(4):459–68. doi:10.1007/s10875-014-0005-8.
Al-Tamemi S, Elnour I, Dennison D. Primary immunodeficiency diseases in Oman: five years’ experience at Sultan Qaboos University Hospital. World Allergy Organ J. 2012;5(5):52–6. doi:10.1097/WOX.0b013e318258830f.
National Center for Statistical Information. Home page. Retrieved from: https://www.ncsi.gov.om/Pages/NCSI.aspx. Accessed 24th August 2016.
Al-herz W, Bousfiha A, Casanova J, Chatila T, Conley ME, Cunningham-rundles C, et al. Primary immunodeficiency diseases : an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol. 2014;5:162. doi:10.3389/fimmu.2014.00162.
Al-Zadjali S, Al-Tamemi S, Elnour I, Alkindi S, Lapoumeroulie C, Al-Maamari S, et al. Clinical and molecular findings of chronic granulomatous disease in Oman: family studies. Clin Genet. 2015;87(2):185–9. doi:10.1111/cge.12351.
Islam MM. The practice of consanguineous marriage in Oman: prevalence, trends and determinants. J Biosoc Sci. 2012;44(5):571–94. doi:10.1017/S0021932012000016.
Marciano BE, Huang C-Y, Joshi G, Rezaei N, Carvalho BC, Allwood Z, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133(4):1134–41. doi:10.1016/j.jaci.2014.02.028.
Al-Maniri A, Al-Rawas O, Al-Tuhami H, Eriksson B, Diwan VK. Towards the elimination of tuberculosis in a develo** country: 25 years of tuberculosis control in Oman. Int J Tuberc Lung Dis. 2007;11(2):175–80.
Clément MC, Mahlaoui N, Mignot C, Le Bihan C, Rabetrano H, Hoang L, et al. Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: analysis of cost-effectiveness based on French real field data. J Allergy Clin Immunol. 2015;135(6):1589–93. doi:10.1016/j.jaci.2015.02.004.
Kuruvilla M, de la Morena MT. Antibiotic prophylaxis in primary immune deficiency disorders. J Allergy Clin Immunol Pract. 2013;1(6):573–82. doi:10.1016/j.jaip.2013.09.013.
Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the Children’s Oncology Group. J Clin Oncol. 2012;30(14):1663–9. doi:10.1200/JCO.2011.37.8018.
Al-Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004–2006). J Clin Immunol. 2008;28(2):186–93.
Naidoo R, Ungerer L, Cooper M, Piennar S, Eley BS. Primary immunodeficiencies: a 27-year review at a tertiary paediatric hospital in Cape Town. South Africa J Clin Immunol. 2011;31:99. doi:10.1007/s10875-010-9465-7.
Acknowledgments
We would like to thank all staff at Sultan Qaboos University Hospital who participated in the care of our patients, all physicians who referred patients for diagnosis and management, and all of our patients and families for their trust. We would like also to thank Dr. Murtadha Al-Khabori for his assistance in the analysis of survival and Professor Samir Al-Adawi for his revision of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study is approved by the Scientific Medical Research Committee and Ethical Committee at the College of Medicine and Health Sciences and Sultan Qaboos University Hospital. The investigators ensured that the study was conducted with full conformance with appropriate laws and regulations. No funding was required to carry out this study.
Conflict of Interest
All authors declare no conflict of interest, real or perceived, in relation to this work.
Rights and permissions
About this article
Cite this article
Al-Tamemi, S., Naseem, S.U.R., Al-Siyabi, N. et al. Primary Immunodeficiency Diseases in Oman: 10-Year Experience in a Tertiary Care Hospital. J Clin Immunol 36, 785–792 (2016). https://doi.org/10.1007/s10875-016-0337-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-016-0337-7